Nearly 50 new biotech medicines in pipeline

There could be as many as 50 new biotechnology medicines approved for commercial use in the coming months, thanks to advances in biotechnology research and development, according to a study released March 7.


Leave a Reply

Your email address will not be published. Required fields are marked *